Compounds > tak 779
Page last updated: 2024-09-05

tak 779 and ancriviroc

tak 779 has been researched along with ancriviroc in 5 studies

Compound Research Comparison

Studies
(tak 779)		Trials
(tak 779)		Recent Studies (post-2010)
(tak 779)		Studies
(ancriviroc)		Trials
(ancriviroc)		Recent Studies (post-2010) (ancriviroc)
1181353022

Protein Interaction Comparison

ProteinTaxonomytak 779 (IC50)ancriviroc (IC50)
C-C chemokine receptor type 5Homo sapiens (human)0.04

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (80.00)29.6817
2010's1 (20.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Clay, WC; Condreay, JP; Ferris, RG; Jenkinson, S; Kerner, SA; Lawrence, WK; McCoy, DC; Smith, CD1
Baroudy, BM; Clader, JW; Dragic, T; Gavrilov, S; Kuhmann, SE; McCombie, SW; Moore, JP; Palani, A; Sakmar, TP; Seibert, C; Smith, SO; Tagat, JR; Tsamis, F; Ying, W1
Carnec, X; Dragic, T; Kajumo, F; Safarian, D; Tsamis, F1
Kondo, M; Saita, Y; Shimizu, Y1
Frimurer, TM; Jensen, PC; Mokrosinski, J; Rosenkilde, MM; Steen, A; Thiele, S1

Other Studies

5 other study(ies) available for tak 779 and ancriviroc

ArticleYear
Development of a novel high-throughput surrogate assay to measure HIV envelope/CCR5/CD4-mediated viral/cell fusion using BacMam baculovirus technology.
    Journal of biomolecular screening, 2003, Volume: 8, Issue:4

    Topics: Amides; Baculoviridae; Butyric Acid; CCR5 Receptor Antagonists; CD4 Antigens; Cell Fusion; Cell Line; Cell Line, Tumor; Cyclic N-Oxides; Dimethyl Sulfoxide; Gene Products, env; Gene Products, rev; Gene Products, tat; HIV; HIV Envelope Protein gp120; HIV Long Terminal Repeat; Humans; Oximes; Piperidines; Plasmids; Pyridines; Quaternary Ammonium Compounds; Receptors, CCR5; rev Gene Products, Human Immunodeficiency Virus; tat Gene Products, Human Immunodeficiency Virus; Transduction, Genetic; Transfection

2003
Interaction of small molecule inhibitors of HIV-1 entry with CCR5.
    Virology, 2006, May-25, Volume: 349, Issue:1

    Topics: Amides; Binding Sites; Cell Line; Cyclic N-Oxides; HIV Fusion Inhibitors; HIV-1; Humans; Models, Molecular; Molecular Structure; Mutagenesis, Site-Directed; Oximes; Piperidines; Protein Structure, Secondary; Pyridines; Quaternary Ammonium Compounds; Receptors, CCR5

2006
An anti-CCR5 monoclonal antibody and small molecule CCR5 antagonists synergize by inhibiting different stages of human immunodeficiency virus type 1 entry.
    Virology, 2006, Sep-01, Volume: 352, Issue:2

    Topics: Amides; Anti-HIV Agents; Antibodies, Monoclonal; CCR5 Receptor Antagonists; Cyclic N-Oxides; Drug Synergism; HeLa Cells; HIV Envelope Protein gp120; HIV Infections; HIV-1; Humans; In Vitro Techniques; Oximes; Peptide Fragments; Piperidines; Pyridines; Quaternary Ammonium Compounds; Receptors, CCR5; Recombinant Proteins

2006
Species selectivity of small-molecular antagonists for the CCR5 chemokine receptor.
    International immunopharmacology, 2007, Dec-05, Volume: 7, Issue:12

    Topics: Amides; Amino Acid Sequence; Amino Acid Substitution; Animals; Binding, Competitive; Calcium; CCR5 Receptor Antagonists; Cell Line; Cell Membrane; Chemokine CCL3; Chemokine CCL4; Chemokine CCL5; Cyclic N-Oxides; Cyclohexanes; HIV Fusion Inhibitors; Humans; Macaca mulatta; Maraviroc; Mice; Molecular Sequence Data; Oximes; Piperidines; Precursor Cells, B-Lymphoid; Pyridines; Quaternary Ammonium Compounds; Radioligand Assay; Receptors, CCR5; Sequence Homology, Amino Acid; Species Specificity; Transfection; Triazoles

2007
Allosteric and orthosteric sites in CC chemokine receptor (CCR5), a chimeric receptor approach.
    The Journal of biological chemistry, 2011, Oct-28, Volume: 286, Issue:43

    Topics: Allosteric Regulation; Amides; Animals; Benzoates; Chemokines; Chlorocebus aethiops; COS Cells; Cyclic N-Oxides; Diketopiperazines; Humans; Oximes; Piperazines; Piperidines; Pyridines; Quaternary Ammonium Compounds; Receptors, CCR2; Receptors, CCR5; Recombinant Fusion Proteins; Spiro Compounds

2011